Cervical Cancer Control, Priorities and New Directions

Monsonego, J, Bosch, FX, Coursaget, P, Cox, JT, Franco, E, Frazer, I, Sankaranarayanan, R, Schiller, J, Singer, A, Wright, T, Kinney, W, Meijer, C and Linder, J (2004) Cervical Cancer Control, Priorities and New Directions. International Journal of Cancer, 108 3: 329-333. doi:10.1002/ijc.11530

Author Monsonego, J
Bosch, FX
Coursaget, P
Cox, JT
Franco, E
Frazer, I
Sankaranarayanan, R
Schiller, J
Singer, A
Wright, T
Kinney, W
Meijer, C
Linder, J
Title Cervical Cancer Control, Priorities and New Directions
Journal name International Journal of Cancer   Check publisher's open access policy
ISSN 0020-7136
Publication date 2004
Sub-type Critical review of research, literature review, critical commentary
DOI 10.1002/ijc.11530
Volume 108
Issue 3
Start page 329
End page 333
Total pages 5
Editor H zur Hausen (Editor-in-Chief)
Place of publication United States
Publisher John Wiley & Sons, Inc.
Collection year 2004
Language eng
Subject CX
320206 Tumor Immunology
730108 Cancer and related disorders
Abstract Cervical cancer is caused by infection with a range of high risk oncogenic human papillomavirus (HPV) types, and it is now accepted that >99% of cervical cancer is initiated by HPV infection. The estimated lifetime risk of cervical cancer is nevertheless relatively low (less than I in 20 for most community based studies). Although sensitivity and specificity of the available diagnostic techniques are suboptimal, Screening for persistent HPV infection is effective in reducing the incidence of cervical cancer. Infection can be detected by molecular techniques or by cytological examination of exfoliated cervical cells. Persistent infection is the single best predictor of risk of cervical cancer.(1) The latest findings of HPV and cervical cancer research need to be widely disseminated to the scientific and medical societies that are updating screening and management protocols, public health professionals, and to women and clinicians. This report reviews current evidence, clinical implications and directions for further research in the prevention, control and management of cervical cancer. We report the conclusions of the Experts' Meeting at the EUROGIN 2003 conference. (C) 2003 Wiley-Liss, Inc.
Keyword Oncology
Cervical Neoplasia
Human Papillomavirus
Hpv Vaccine
Human-papillomavirus Infection
Squamous Intraepithelial Lesions
Undetermined Significance
Management Strategies
Visual Inspection
Particle Vaccine
Adult Volunteers
Q-Index Code CX
Additional Notes This document is a journal review.

Document type: Journal Article
Sub-type: Critical review of research, literature review, critical commentary
Collections: Excellence in Research Australia (ERA) - Collection
UQ Diamantina Institute Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 64 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 94 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 15 Aug 2007, 04:08:45 EST